Emerging treatments are expected to help fill the need for safer and more effective therapies for atopic dermatitis (AD). Both systemic and topical treatments are needed to provide full and complete treatment for patients with AD. Targeting the specific axis or axes that control AD may contribute to developing personalized approaches to treatment
Research has demonstrated that staph aureus is in increased supply on the skin of atopic dermatitis patients coupled with less overall diversity in the number of bacteria on their skin, suggesting therapies that achieve balance in the skin microbiome could help to manage atopic dermatitis.
The use of olive or sunflower oil on newborn babies’ skin damages the skin barrier, researchers from the University of Manchester recently reported. This latest study adds to the conflicting information around caring for newborn skin and how to manage conditions like atopic dermatitis. Learn more
Older non-specific immunomodulatory drugs and off-label use of several biologic agents offer treatment options for children with severe atopic dermatitis (AD). However, the future should bring therapies specifically developed for treatment of AD investigated in children.
Patients with moderate to severe atopic dermatitis (AD)—or eczema—may be successfully treated using a rheumatoid arthritis (RA) drug recently shown to reverse 2 other skin conditions, vitiligo and alopecia areata, according to findings published early online in the Journal of the American Academy of Dermatology.